MRÁZ, Marek, L.G. CHEN, L.Z. RASSENTI, E.M. GHIA, H.Y. LI, K. JEPSEN, E.N. SMITH, K. MESSER, K.A. FRAZER and T.J. KIPPS. miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1. Blood. WASHINGTON: American Society of Hematology, vol. 124, No 1, p. 84-95. ISSN 0006-4971. doi:10.1182/blood-2013-09-527234. 2014.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1
Authors MRÁZ, Marek (203 Czech Republic, guarantor, belonging to the institution), L.G. CHEN (840 United States of America), L.Z. RASSENTI (840 United States of America), E.M. GHIA (840 United States of America), H.Y. LI (840 United States of America), K. JEPSEN (840 United States of America), E.N. SMITH (840 United States of America), K. MESSER (840 United States of America), K.A. FRAZER (840 United States of America) and T.J. KIPPS (840 United States of America).
Edition Blood, WASHINGTON, American Society of Hematology, 2014, 0006-4971.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 10.452
RIV identification code RIV/00216224:14740/14:00078422
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1182/blood-2013-09-527234
UT WoS 000342618300015
Keywords in English GENE MUTATION STATUS; DOWN-REGULATION; C-MYB; DISEASE PROGRESSION; PROTEIN EXPRESSION; CD38 EXPRESSION; CLL PATIENTS; MICRORNAS; ZAP-70; APOPTOSIS
Tags kontrola MP, MP, rivok
Tags International impact, Reviewed
Changed by Changed by: Martina Prášilová, učo 342282. Changed: 6/3/2015 11:02.
Abstract
We examined the microRNAs (miRNAs) expressed in chronic lymphocytic leukemia (CLL) and identified miR-150 as the most abundant, but with leukemia cell expression levels that varied among patients. CLL cells that expressed zeta-chain-associated protein of 70 kDa (ZAP-70) or that used unmutated immunoglobulin heavy chain variable (IGHV) genes, each had a median expression level of miR-150 that was significantly lower than that of ZAP-70-negative CLL cells or those that used mutated IGHV genes. In samples stratified for expression of miR-150, CLL cells with low-level miR-150 expressed relatively higher levels of forkhead box P1 (FOXP1) and GRB2-associated binding protein 1 (GAB1), genes with 3' untranslated regions having evolutionary-conserved binding sites for miR-150. High-level expression of miR-150 could repress expression of these genes, which encode proteins that enhance B-cell receptor signaling, a putative CLL-growth/survival signal. Also, high-level expression of miR-150 was a significant independent predictor of longer treatment-free survival or overall survival, whereas an inverse association was observed for high-level expression of GAB1 or FOXP1 for overall survival. This study demonstrates that expression of miR-150 can influence the relative expression of GAB1 and FOXP1 and the signaling potential of the B-cell receptor, thereby possibly accounting for the noted association of expression of miR-150 and disease outcome.
Links
EE2.3.30.0009, research and development projectName: Zaměstnáním čerstvých absolventů doktorského studia k vědecké excelenci
PrintDisplayed: 20/4/2024 07:26